<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0200849.ref025">
 <label>25</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Hurt</surname>
   <given-names>AC</given-names>
  </name>, 
  <name>
   <surname>Chotpitayasunondh</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Cox</surname>
   <given-names>NJ</given-names>
  </name>, 
  <name>
   <surname>Daniels</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Fry</surname>
   <given-names>AM</given-names>
  </name>, 
  <name>
   <surname>Gubareva</surname>
   <given-names>LV</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives</article-title>. 
  <source>The Lancet Infectious diseases</source>. 
  <year>2012</year>;
  <volume>12</volume>(
  <issue>3</issue>):
  <fpage>240</fpage>â€“
  <lpage>8</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(11)70318-8</pub-id>
  <?supplied-pmid 22186145?>
  <pub-id pub-id-type="pmid">22186145</pub-id>
 </mixed-citation>
</ref>
